Through the 90-day period concluding February 07, 2026, Beam Therapeutics's top three insider stakeholders include Director Robert Nelsen (3.54Mn shares), TenPercentOwner Venture Partners Ix, Llc Arch (2.95Mn shares), Director Kristina Burow (2.93Mn shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Robert Nelsen | 3,535,572 | 02 Apr, 2021 | |
| Venture Partners Ix, Llc Arch | 2,949,630 | 02 Jul, 2021 | |
| Kristina Burow | 2,933,586 | 02 Jul, 2021 | |
| Llc Fmr | 1,139,443 | 29 Oct, 2025 | |
| John M. Evans | Ceo | 1,089,667 | 02 Feb, 2026 |
| Giuseppe Ciaramella | President | 190,216 | 03 Apr, 2025 |
| Christine Bellon | Chief Legal Officer | 95,667 | 26 Jan, 2026 |
| Terry-Ann Burrell | Chief Financial Officer | 82,637 | 29 Apr, 2024 |
| Amy Simon | Chief Medical Officer | 77,364 | 05 Jan, 2026 |
| Sravan Kumar Emany | Chief Financial Officer | 73,706 | 05 Jan, 2026 |
| Bethany J Cavanagh | Svp And Finance And Treasurer | 34,813 | 26 Jan, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 30 Jan, 2026 | John M. Evans | Common Stock | D | 22,094 | $28.27 | 989,573 | D | S |
| 30 Jan, 2026 | John M. Evans | Common Stock | D | 2,906 | $29.00 | 986,667 | D | S |
| 30 Jan, 2026 | John M. Evans | Common Stock | A | 25,000 | $0.67 | 1,011,667 | D | M |
| 29 Jan, 2026 | John M. Evans | Common Stock | A | 5,664 | $0.67 | 1,011,667 | D | M |
| 29 Jan, 2026 | John M. Evans | Common Stock | A | 19,336 | $0.67 | 1,006,003 | D | M |
| 29 Jan, 2026 | John M. Evans | Common Stock | D | 8,667 | $29.74 | 986,667 | D | S |
| 29 Jan, 2026 | John M. Evans | Common Stock | D | 16,333 | $29.19 | 995,334 | D | S |
| 22 Jan, 2026 | Christine Bellon | Common Stock | D | 1,371 | $34.00 | 95,667 | D | S |
| 22 Jan, 2026 | Bethany J Cavanagh | Common Stock | D | 6,198 | $35.00 | 34,813 | D | S |
| 20 Jan, 2026 | Bethany J Cavanagh | Common Stock | D | 3,034 | $30.12 | 41,011 | D | S |
| 15 Jan, 2026 | Christine Bellon | Common Stock | D | 2,111 | $33.62 | 113,556 | D | S |
| 15 Jan, 2026 | Christine Bellon | Common Stock | D | 559 | $35.40 | 97,038 | D | S |
| 15 Jan, 2026 | Christine Bellon | Common Stock | D | 15,959 | $34.72 | 97,597 | D | S |
| 31 Dec, 2025 | Sravan Kumar Emany | Common Stock | D | 6,294 | $27.10 | 73,706 | D | S |
| 31 Dec, 2025 | Christine Bellon | Common Stock | D | 1,254 | $27.10 | 115,667 | D | S |
| 31 Dec, 2025 | Amy Simon | Common Stock | A | 12,500 | $0.00 | 77,364 | D | A |
| 31 Dec, 2025 | Amy Simon | - | - | 77,364 | D | |||
| 27 Oct, 2025 | Llc Fmr | - | - | 1,139,443 | I | |||
| 27 Oct, 2025 | Llc Fmr | Common Stock | D | 459 | $26.68 | 1,139,443 | I | S |
| 06 Oct, 2025 | Llc Fmr | Common Stock | D | 1,232,434 | $0.00 | 1,139,443 | I | G |